Rapport Therapeutics (RAPP) Shares Issued (2023 - 2026)

Rapport Therapeutics (RAPP) has 4 years of Shares Issued data on file, last reported at $2.5 million in Q1 2026.

• On a quarterly basis, Shares Issued rose 169.52% year-over-year to $2.5 million in Q1 2026; TTM through Mar 2026 was $2.5 million, a 169.52% increase from a year earlier, with the FY2025 full-year figure at $6.3 million, up 50.07% from the prior year.
• Shares Issued for Q1 2026 stood at $2.5 million, down from $6.3 million in the prior quarter.
• Over the last five years, Shares Issued for RAPP reached as high as $6.3 million in Q4 2025 and fell as low as $281573.0 in Q3 2024.
• Historically, Shares Issued has averaged $2.5 million across 4 years, with a median of $1.7 million in 2025.
• On a YoY basis, Shares Issued climbed as much as 514.56% in 2025 and fell as far as 62.52% in 2025.
• Year by year, Shares Issued stood at $1.4 million in 2023, then soared by 204.36% to $4.2 million in 2024, then surged by 50.07% to $6.3 million in 2025, then plunged by 60.8% to $2.5 million in 2026.
• Per Business Quant data, the three most recent Shares Issued figures were $2.5 million in Q1 2026, $6.3 million in Q4 2025, and $1.7 million in Q3 2025.